trending Market Intelligence /marketintelligence/en/news-insights/trending/W7e1M06HtqtQAjwHqlCwQQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

New York Life confirms $6B+ deal for Cigna's nonhealth business

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February

Lemonade Growing Premiums Faster Than Esurance's Homeowners Business Did


New York Life confirms $6B+ deal for Cigna's nonhealth business

New York Life Insurance Co. is acquiring Cigna Corp.'s group life and disability insurance business for $6.3 billion.

The deal is expected to close in the third quarter of 2020.

After-tax proceeds from the transaction for Cigna are expected to be approximately $5.3 billion. The managed care company expects to use the proceeds for share repurchases and repayment of debt in 2020. The impact of the transaction to Cigna's EPS is expected to be neutral in 2020 and modestly accretive in 2021.

The Cigna group life employees, as well as employees who primarily support the acquired business, will transfer to New York Life.

Credit Suisse Securities (USA) LLC is acting as financial adviser and Debevoise & Plimpton LLP is serving as legal adviser to New York Life.

BofA Securities is acting as financial adviser, Sidley Austin LLP is serving as lead legal counsel and Paul Weiss Rifkind Wharton & Garrison LLP is serving as antitrust counsel to Cigna. Wachtell Lipton Rosen & Katz is also advising Cigna on the transaction.

Cigna’s board of directors has also increased the company’s share repurchase authority by $3.0 billion to an aggregate amount of $4.0 billion.